2023
DOI: 10.3389/bjbs.2023.10794
|View full text |Cite
|
Sign up to set email alerts
|

Faecalibacterium prausnitzii Improves Lipid Metabolism Disorder and Insulin Resistance in Type 2 Diabetic Mice

Abstract: Purpose: Additional effective therapeutic strategies for Type 2 diabetes (T2D) patients are urgently needed. Gut microbiota plays an important role in T2D development and is a promising treatment strategy for T2D patients. Faecalibacterium prausnitzii (F. prausnitzii) is regarded as one of the most important bacterial indicators for a healthy gut, but the mechanisms of its anti-diabetic properties are still unclear.Methods and Results: The abundance of F. prausnitzii in feces of patients with T2D was detected … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 43 publications
0
0
0
Order By: Relevance
“…In particular, A. muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium were the taxa selected as relevant for the study of prevention strategies against metabolic diseases [242]. For instance, Faecalibacterium prausnitzii is a butyrate-producing bacteria inversely associated with type II diabetes, also described as a therapeutic option to decrease fasting glucose and IR in diabetic patients [243]. Thus, SCFA-producing bacteria (such as A. muciniphila) might be a mechanistic link between exercise-inducing irisin and BDNF and the positive impact on NPSs in AD.…”
Section: Irisin and Bdnf As "Ideal" Players Connecting Physical Activ...mentioning
confidence: 99%
“…In particular, A. muciniphila, Bifidobacterium longum, Clostridium leptum group, Faecalibacterium prausnitzii, and Faecalibacterium were the taxa selected as relevant for the study of prevention strategies against metabolic diseases [242]. For instance, Faecalibacterium prausnitzii is a butyrate-producing bacteria inversely associated with type II diabetes, also described as a therapeutic option to decrease fasting glucose and IR in diabetic patients [243]. Thus, SCFA-producing bacteria (such as A. muciniphila) might be a mechanistic link between exercise-inducing irisin and BDNF and the positive impact on NPSs in AD.…”
Section: Irisin and Bdnf As "Ideal" Players Connecting Physical Activ...mentioning
confidence: 99%